It is inaccurate to say that people who have their lungs pumped will not live long. Pulmonary fluid aspiration usually refers to the extraction of pleural fluid by thoracocentesis, which is a clinical diagnostic and therapeutic means, and generally does not affect the patient’s life expectancy. The survival time of the patient generally depends on the primary disease causing the pleural effusion, as well as the patient’s underlying state. Pleural effusion can be seen in a variety of diseases, chest diseases (such as tuberculosis, pneumonia, pleurisy, lung cancer, etc.), extrapulmonary diseases (such as hypoproteinemia, cirrhosis of the liver, nephrotic syndrome, etc.), generally through active treatment of the primary disease, if necessary, thoracentesis to extract pleural effusion, patients generally have a better prognosis, usually puncture fluid extraction will not affect the patient’s life expectancy. In some cases of malignant effusion caused by pleural tumors, the prognosis of patients is generally poorer, but through active treatment, such as thoracentesis and aspiration, the patient’s symptoms can be effectively improved and the quality of life can be enhanced.